October 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System  
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process


Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
W911NF-17-S-0002 01
April 2017 - 31 March 2022

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding. Whitepapers and proposals will be evaluated only if they are for fundamental scientific study and experimentation directed toward advancing the scientific state of the art or increasing basic knowledge and understanding. 
Due Dates: Open until Mar. 31, 2022
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W911NF-17-S-0002


Ongoing Postdocs/Junior Faculty Non-federal Pediatric Brain Tumors

A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of pediatric low grade glioma brain tumor (PLGA) tumors will be considered.
Due Dates: Letters of Intent are accepted on an ongoing basis, and are reviewed by an expert panel. Based on this feedback, selected applicants will be invited to submit a full proposal
Amount & Project Period: Funding is based on size, complexity, and potential impact of project, and can be awarded over a one-, two-, or three-year period.
Eligibility: Investigators in the early years of their careers are encouraged to apply.  
Contact: Office of Sponsored Research (x6804)
Link: Apply for an AKBTC Sponsored Grant
R01 NIH


To Be Announced All Ranks Federal See Opportunities Below

Cancer Moonshot

Implementation Teams have identified nine upcoming opportunities addressing the goals of the Cancer Moonshot.  These funding opportunities that have been approved by the NCI Board of Scientific Advisors will be published over the coming months with funding anticipated in fiscal year 2018.  The nine opportunities are listed below and all investigators are encouraged to sign up to receive automatic updates as more information becomes available.
Contact: Office of Sponsored Research (x6804)
Links: 1.     Immuno-Oncology Translational Network (IOTN)
2.     Pediatric Immunotherapy Discovery and Development Network (PI-DDN)
3.    Mechanisms of Cancer Drug Resistance and Sensitivity Network Coordinating Center
4.     Collaborative Research Network for Fusion Oncoproteins in Childhood Cancers
5.     Common Terminology Criteria for Adverse Events (CTCAE) and Patient Reported Outcomes-CTCAE (PRO-CTCAE)
6.     Improving Management of Symptoms Across Cancer Treatments (IMPACT)
7.     Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes
8.     Accelerating Colorectal Cancer Screening and Follow-Up Through Implementation Science (ACCSIS)
9.    Human Tumor Atlas (HTA) Network  


Updated information
September 21 All Ranks Non-federal Career Development

Conquer Cancer Foundation
Grants & Awards

 
Due Dates: Sept. 19 (OSR) Ι Sept. 21 (Sponsor)
Deadline extended to Oct. 05, with the stipulation that applicantion is initiated by 11:59 p.m. EST on September 21.
Contact: Office of Sponsored Research (x6804)
Primary Link: Funding Opportunities
 

Career Development Award

This award provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. Research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed.
Amount & Project Period: $200,000 - 3 years
Eligibility: Be a physician (MD, DO or international equiv.) in 1st to 3rd year of a full-time primary faculty appointment in a clinical department at an academic medical institution at proposal submission.   Faculty appointment may begin w/entry-level faculty position;
Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research;
Be an ASCO Member or have submitted a membership application w/application. To apply for membership, or to renew existing membership, please visit http://www.asco.org/membership.  
Be able to commit more than 50% of full-time effort in research (applies to total research, not just the proposed project) during award period.
See Eligibility for additional detail.
Link: Career Development Award
 

Young Investigator Award

This award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.
Amount & Project Period: $50,000 - 1 year
Eligibility: Be a physician (MD, DO, or international equiv.) currently in last 2 years of final subspecialty training and w/in 10 years of obtaining medical degree at time of proposal submission;
An MD, PhD is eligible if both degrees are completed prior to start of grant period.
Be planning an investigative career in clinical oncology.
Be an ASCO member or have submitted a membership application w/application. To apply for membership, or to renew existing membership, please visit http://www.asco.org/membership.
Be able to commit at least 60% of full- time effort in research (applies to total research, not just proposed project) during award period.
See Eligibility for additional detail.
Link: Young Investigator Award



September 22 (LOI) Established Investigators Non-federal Hematological Malignancies

Leukemia & Lymphoma Society
Specialized Center of Research (SCOR)

The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. To bring together established investigators from one or several institutions to develop a focused research program and enhance interdisciplinary research. There must be objective evidence of interdisciplinary research among the Projects and Cores.
Due Dates: Sept. 22 (Letter of Intent)
Invited Applications: Mar. 01 (OSR) Ι Mar. 3 (Sponsor)
Amount & Project Period: $1,000,000/yr. (TOTAL) - 5 years
Eligibility: Must hold a PhD, MD, DVM or equivalent and be affiliated with a non-profit institution
Contact: Office of Sponsored Research (x6804)
Links: Overview | Fluxx (Research Portal)
R21 NCI


September 26 All Ranks Federal Molecular & Cellular Analysis

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.
Due Dates: Letter of Intent requested 30 days prior to due date.
Sept. 22 (OSR) Ι Sept. 26 (Sponsor)
Amount & Project Period: $400,000 (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-CA-17-010
Companion FOA: RFA-CA-17-011 (R33)
R21 NCI

September 26 All Ranks Federal Biospecimen

Innovative Technologies for Cancer-Relevant Biospecimen Science

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. It will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions.
Due Dates: Letter of Intent requested 30 days prior to due date.
Sept. 22 (OSR) Ι Sept. 26 (Sponsor)
Amount & Project Period: $400,000 (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-CA-17-012
Companion FOA: RFA-CA-17-013 (R33)


NEW
September 29 (LOI) All Ranks Non-Federal Hematological Malignancies

Leukemia and Lymphoma Society
Translational Research

Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. Application should have a clear plan for clinical translation of studies proposed and results expected.  Proposed research should be clinically directed or clinically translatable in hematologic malignancies that is intended to develop innovative approaches to treatment, diagnosis, or prevention.
Due Dates: Sept. 27 (Letter of Intent) (3:00, pm ET)
Full applications due: Nov. 13 (OSR) Ι Nov. 15, 2017 (3:00, pm ET) (Sponsor)
Amount & Project Period: $600,000 (Total Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link:  Guidelines


NEW
September 29 (Pre-Application) See Below Federal Breast

Breast Cancer Research Program (BCRP)

Due Dates: Sept. 29 (Pre-application)
Invited Applications:  Dec. 19 (OSR) Ι Dec. 21 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: BCRP Program Announcements Ι Pre-Application Site
 

Breakthrough Award Levels 3 & 4
W81XWH-17-BCRP-BREAKTHROUGH2-FL34

Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. Two different funding levels, based on the scope of the research, are available: Funding Level 3:  Advanced translational studies having potential for near-term clinical investigation. Small-scale clinical trials may apply.
Funding Level 4: Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer.  Near-term clinical impact is expected. Human clinical testing is required. PIs are expected to have experience in successfully leading large-scale projects. (Note: An invited oral presentation is a requirement for application review of Funding Level 4 projects)
Amount & Project Period: Level 3: $2.5M - 4 years
Partnering Option: $4M (Combined direct Costs)
Level 4: $10M - 3 years
Partnering Option: Same funding limit
The Partnering PI Option is structured to accommodate two PIs referred to as the Initiating PI and the Partnering PI, each of whom will receive a separate award. (See FOA for details)
Eligibility: Investigators at all academic levels
Note: Each individual may submit only one Funding Level 3 pre-application and one Funding Level 4 pre-application as a PI or Initiating PI.
PA Link: W81XWH-17-BCRP-BREAKTHROUGH2-FL34
 

Distinguished Investigator Award II
W81XWH-17-BCRP-DIA2

This award enables established visionary leaders from any field to pursue innovative ideas that could accelerate progress toward ending breast cancer. The central feature of the Distinguished Investigator Award is that the PI must propose research that is a fundamental shift from his/her track record of research and addresses one or more BCRP overarching challenge(s).
Amount & Project Period: $3M (Direct Costs) - 4 years
Eligibility: Must be at or above the level of Assistant Professor (or equivalent) and be more than 6 years beyond the last mentored position.
PA Link: W81XWH-17-BCRP-DIA2
 

Innovator Award II
W81XWH-17-BCRP-INNOV2

This award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer.
Amount & Project Period: $5M (Direct Costs) - 4 years
Eligibility: Must be at or above Associate Professor (or equiv.)
PA Link: W81XWH-17-BCRP-INNOV2


September 29 (LOI) All Faculty Ranks Non-federal Blood Cancers/Translational

Leukemia & Lymphoma Society
Translational Research Program (TRP)

This program funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.  The goal of translational research is to reduce the time between laboratory findings and actual treatment.
Due Dates: Sept. 29 (Letter of Intent)
Full Applications:  Nov. 13 (OSR) Ι Nov. 15 (Sponsor)
Amount & Project Period: $200,000/yr. (Total) - 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: TRP application process | FLUXX (Research Portal)


September 30 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1


October 01 Postdocs Non-Federal Immunology

Cancer Research Institute
CRI Irvington Postdoctoral Fellowship

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists who wish to receive training in cancer immunology. The Institute seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology that directly impacts our understanding of the immune system's role in cancer risk, tumor initiation, progression, metastasis, host response to tumor and/or the treatment of cancer.
Due Dates: Sept. 28 (OSR) Ι Oct. 01 (Sponsor)
Amount & Project Period: Funding is comprised of a progressive stipend starting at $55,000 and Expense allowance  ($1,500) - 3 years
Eligibility: Must be working in areas directly related to cancer immunology.  
Must have a doctoral degree by date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
Must not have 5 or more years of relevant postdoctoral experience, with the exception of M.D. applicants, who should not include years of residency in this calculation. ·
Must not have 3 or more years in a sponsor's laboratory by the start date of fellowship.
Contact: Office of Sponsored Research (x6804)
Link: Guidelines  Ι  Application Instructions

October 01 Junior Faculty Non-Federal Career Development

Research Foundation of the American Society of Colon and Rectal Surgeons
Career Development Award

This award focuses on career development and mentorship of the individual rather than solely on the research proposal. The award is intended for the academic investigator demonstrating significant creativity in research relevant to the pathophysiology or management of diseases of the small bowel, colon, rectum, or anus.
Due Dates: Aug. 03 (OSR) Ι Oct. 01 (Sponsor)    
Next Semi-annual Due Date: March 01
Amount & Project Period: $150,000 - 2 years
Eligibility: Must be w/in 5 years of first full-time faculty appointment; Must be a U.S. or Canadian citizen who has completed an approved colorectal surgery training program; and be a member of ASCRS;
Must not currently have or have previously received a career development award
Contact: Office of Sponsored Research (x6804)
Link: Application Instructions



October 01 PostDocs/New Investigators Non-federal Regenerative Medicine and Cell Therapy

The Sartorius & Science Prize for Regenerative Medicine and Cell Therapy

This prize is focused on basic or translational research that advances regenerative medicine and cell therapy that advances regenerative medicine and cell therapy; for example cell-, gene-, or immunotherapy, tissue engineering, and materials engineering.
Due Dates: Oct. 01 (Sponsor)
Amount & Project Period: Cash prize of $25,000 and a publication of essay in Science Online.  Winners also receive a 5-year membership to the American Association for the Advancement of Science (AAAS).
Eligibility: Entrant must have an advanced degree received on or after January 1, 2007. Candidates for MD/PhD degrees are eligible if either their Ph.D. or final degree was awarded after January 1, 2007;
Entrant must have performed the work described in the essay.
Contact: sartoriusscience@aaas.org
Links: Overview |  How to Enter




October 01 (LOI) All Faculty Ranks Non-federal Blood Cancers/Translational

Rising Tide Foundation for Cancer Research and Leukemia & Lymphoma Society
RTFCCR/LLS Patient-Focused Prevention

The Rising Tide Foundation for Clinical Cancer Research and the Leukemia & Lymphoma Society offer this competitive grant to advance breakthroughs in prevention for blood cancers.  There are 4 RFP-suggested topics:  Clinical Trials, Biomarker Evaluation, Use of Experimental Systems, and Drug the Undruggable described at the program site. 
Grants must be translational in nature and ideally will have a clinical trial proposed, or could lead to a clinical trial. Applications that are solely laboratory-based without consideration of using patient samples or future clinical testing will not be accepted for review.
Due Dates: Oct. 31 (Letter of Intent)
Full Applications:  Jan. 30 (OSR) Ι Feb. 01, 2018 (Sponsor)
Amount & Project Period: $0.6 - 1.2 M
Eligibility: All Faculty Ranks  
Contact: Office of Sponsored Research (x6804)
Sponsor Contact: Eveline Mumenthaler, Director of RTFCCR (Eveline.mumenthaler@risingtide.ch) or
Lee Greenberger, Chief Scientific Officer of LLS (researchprograms@lls.org)
Links: Academic Grants
Patient-focused Prevention
proposalCENTRAL (Submission Site)



October 03 All Ranks Federal Mathematical Analysis

National Science Foundation Division of Mathematical Sciences
Analysis Program

Research supported by the Analysis Program provides the theoretical underpinning for the majority of applications of the mathematical sciences to other scientific disciplines.
Due Dates: Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Amount & Project Period: Amount not stated - 3 to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PD 16-1281 | Mathematical Sciences
R01 NCI


October 05 All Ranks Federal Molecular

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion

The purpose of this FOA is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus of this FOA is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 5 yrs
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-330 (R01)
R01 NIH

October 05 All Ranks Federal Small Molecule

Discovery of Small Molecule Immunomodulators for Cancer Therapy

The purpose of this FOA is to promote the discovery of novel small molecules that may enhance the ability of the immune system to selectively recognize and attack cancer cells. Investigators from multiple scientific disciplines (immuno-oncology, tumor biology, screening technology, medicinal chemistry, and pharmacology) are encouraged to establish collaborative teams to discover and develop novel small molecule immunomodulators for cancer therapy.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 4 yrs
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-331
R01 NCI

October 05 All Ranks Federal Residential History

Integration of Individual Residential Histories into Cancer Research

The purpose is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes, and to encourage the development of complex analytical strategies in support of substantive investigation.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-298
Companion Link: PA-17-295 (R21)
R01 NIH
NCI is a participating Institute
October 05 All Ranks Federal HIV and Aging

Multidisciplinary Studies of HIV/AIDS and Aging  

NCI seeks to foster research studies to help understand how aging in the presence of chronic HIV infection affects the risk, spectrum and biology of cancer (AIDS-defining and non-AIDS-defining cancers).
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-321
Companion FOA: PAR-17-320 (R21)



NEW
October 06 All Ranks Non-Federal Clinical Trial/Patient Services

Community Foundation of Broward Cancel Cancer

To support research and promising clinical trials on the most prevalent and deadliest cancers and provide financial support to cancer patients and their families.
Due Dates: Oct. 04 (OSR) Ι Oct. 06 (Sponsor)
Amount & Project Period: $100,000 (Total Costs) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι PhilNet Portal


October 06 (LOI) See Below Non-Federal Melanoma

Melanoma Research Alliance
Team Science Award

This team science award is designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. It will support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging and/or treatment of melanoma.
Due Dates: Oct. 06 (Letter of Intent)
Invited applications: Jan. 05 (OSR) Ι Jan. 09 (Sponsor)
Amount & Project Period: $900,000 (Total Costs) - 3 years  
Eligibility: Must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι RFP
R01 NIH

October 11 All Ranks Federal Health Disparities

U.S. Tobacco Control Policies to Reduce Health Disparities

The purpose is to support observational or intervention research focused on reducing health disparities in tobacco use in the U.S. It is intended to stimulate scientific inquiry focused on innovative tobacco control policies.  Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. 
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 09 (OSR) Ι Oct. 11 (Sponsor)
Additional due dates: June 13, 2018; Oct. 11, 2018; June 13, 2019; Oct. 11, 2019; June 15, 2020
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-217
PAR-17-218 (R21)


NEW
October 13 (LOI) All Ranks non-Federal Health Care

Robert Wood Johnson Foundation
Building Trust and Mutual Respect to Improves Health Care

 This call for proposals will fund empirical research studies to help better understand how to build trust and mutual respect to meet vulnerable patients' health care needs. Proposals could evaluate multi-component interventions/programs and policies or develop and test scalable measurement instruments designed to build trust and mutual respect.
Due Dates: Oct. 13 (Letter of Intent) (3:00, pm ET)
Invited applications: Jan. 16 (OSR) Jan. 18, 2017 (Sponsor)
Amount & Project Period: $250,000 (Total Costs) - 18-24 months  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Guidelines Ι Apply Online



October 13 (LOI) All Ranks Non-Federal Bone Marrow Failure and Cancer

Fanconi Anemia Research Fund, Inc.
Research Grants

Supports research focusing on rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia.   There is particular interest in supporting interdisciplinary and translational research efforts including:
- Understanding how alteration of the Fanconi anemia genes and their products lead to the clinical manifestations of Fanconi anemia.
- Determining causes of bone marrow failure, myelodysplasia and leukemia in individuals with Fanconi anemia, and developing strategies to prevent, treat, and cure these disorders. 
- Defining the pathogenesis of Fanconi anemia-associated cancers, and developing strategies for prevention, early detection, treatment and cure.
Due Dates: Oct. 13 (Letter of Intent)
Invited Applications: Jan. 31 (OSR) Ι Feb. 02, 2018 (Sponsor)
Amount & Project Period: $150,000 - $175,000 over a two year period.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Applications
Admin Supplement NIH
NCI is a participating Institute
October 15 See Below Federal Dietary Supplements

Administrative Supplements for Research on Dietary Supplements

The purpose of these supplements is to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. 
Due Dates: Oct. 13 (OSR) Ι Oct. 15 (Sponsor)
Addnl. Due Dates:  Jan. 15 and Apr. 15, 2018
Amount & Project Period: Up to $100,000 (Direct Costs) - 1 year (Must be w/in currently approved project period for existing parent award. 
Eligibility: Only active awards w/at least 18 months remaining at time of submission will be considered.  Awards in no-cost extension periods are not allowed to submit an application.  
Contact: Office of Sponsored Research (x6804)
Link: PA-17-307


NEW
October 16 All Ranks Non-Federal Ovarian

Rivkin Center for Ovarian Cancer
Bridge Funding Award

The purpose of Bridge Funding is to allow researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. Investigator-initiated projects in all areas of ovarian cancer research are eligible. Special consideration will be given to research that has clinical applicability.
Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor) (5:00p.m., EST)
Amount & Project Period: $30,000 (Total Costs) - 6 months  
Eligibility: Must have submitted an NIH (R01, R21, K08, K23, K99) or DoD proposal
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι RFA Ι Guidelines Ι proposalCENTRAL
R21 NIH


October 16 All Ranks Federal Health Disparities

Leveraging Population-based Cancer Registry Data  to Study Health Disparities

The goal is to efficiently use existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. This FOA will support the study of factors influencing observed health disparities within the framework of population-based cancer registries by the inclusion of data not routinely collected by or linked to the registries. Studies should be hypothesis-driven and multidisciplinary approaches are encouraged. Investigators are encouraged to leverage data already collected by the registries to investigate the determinates of health disparities.
Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-288
Companion FOA: PA-17-289 (R01)
R21 NIH
NCI is a participating Institute
October 16 All Ranks Federal Genomics

Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program  

The purpose of this FOA is to solicit exploratory or developmental research applications that identify, analyze, and address the ethical, legal and social implications (ELSI) of these genetic and genomic advances for individuals, families, communities and society more broadly. 
Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-323
Companion FOA: PA-17-324 (R03)
PA-17-325 (R01) Due date Oct 05




October 16 All Faculty Ranks Non-Federal Immunotherapy Melanoma

American Cancer Society & Melanoma Research Alliance
Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers - Pilot Award

This initiative by the American Cancer Society and the Melanoma Research Alliance will award pilot or exploratory projects whose purpose is to test interventions, develop research methodologies and explore novel areas of research leading towards reduction of immune related adverse events (irAEs) and improvement of overall outcomes for cancer patients treated with checkpoint immunotherapy.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Paper application copy due Oct. 17 (Sponsor)
Amount & Project Period: $200,000 (Total) - 2 years
Eligibility: Independent investigators at all stages 
PI must hold a doctorate degree (M.D., Ph.D., or equiv.) and have full-time faculty position or equiv.
Multiple PIs or Co-PIs are not allowed.
Contact: Office of Sponsored Research (x6804)
Link: Pilot Award Policies and Instructions (PDF)
proposalCENTRAL (submission site)


Fall Cycle
October 16 See Below Non-federal Career Development

American Cancer Society  -  Fall 2017

Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Note: Paper copes are due one day after submission of electronic copy
Contact: Office of Sponsored Research (x6804)
Primary  Links: Grant Types Ι proposalCENTRAL
 

Postdoctoral Fellowships

To support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer.
Amount & Project Period: Progressive stipends: $48,000, $50,000, and $52,000, plus a $4,000/yr. fellowship allowance - 3 years
Eligibility: Must be a U.S. citizen or permanent resident;
Must obtain doctoral degree prior to start date;
Cannot have held a PhD or MD for more than 4 years at time of submission
Links: Overview Ι Policies and Instructions
 

Mentored Research Scholar

The goal is to support junior faculty members to become independent investigators as either clinician scientists or cancer control researchers. This grant is for individuals whose training primarily has prepared them for a career as a clinician or to conduct clinical or cancer control research, with the goal of strengthening their capacity to conduct cancer research.
Amount & Project Period: $135,000/yr.  (Direct Costs) - 5 years
Eligibility: Must be a U.S. citizen or permanent resident
Be w/in first four years of a full time  faculty appointment or equiv. and must provide a justification that supports the need for mentoring;
May not have indepenbdent research program and/or independent extramural research funding (R01 or equiv.)
See Policies & Instructions for additional detail.
Links: Overview | Policies & Instructions
 

Research Scholar Grants (RSG)

The RSG is intended to provide the resources for investigator-initiated research in a variety of cancer-relevant areas.
Amount & Project Period: $165,000/yr. (Direct Costs) - 4 years
Eligibility: Must be a U.S. citizen or permanent resident;
Must have an independent research or faculty position and be w/in six years of first academic appointment;
See Policies & Instructions for additional detail.
Links: Overview | Policies & Instructions
 

RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

Pilot/exploratory research grants in palliative care of cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of competing successfully for larger grants.
Amount & Project Period: $60,000/yr. (Direct Costs) - 2 years
Eligibility: Must be a U.S. citizen or permanent resident;
Must have a full-time faculty position or equiv.
Links: Overview| Policies & Instructions
U01 NCI


October 20 (LOi) All Ranks Federal Informatics

Early-Stage Development of Informatics Technologies for Cancer Research and Management 

For the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.
Due Dates: Oct. 20 (Letter of Intent)
Nov. 16 (OSR) Ι Nov. 20 (Sponsor)
Additional Due Date:  June 14, 2018
Amount & Project Period: $300,000 Direct Costs (excl. consortium F&A) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-332
Companion FOAs: PAR-15-334, R21 - Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management PAR-15-331, U24 - Advanced Development of Informatics Technologies for Cancer Research and Management
PAR-15-333, U24 - Sustained Support for Informatics Resources for Cancer Research and Management
U01 NIH

October 23 All Ranks Federal Oncology/Thrombosis

Consortium Linking Oncology with Thrombosis (CLOT)

The goal is to establish a program which will provide support for the collaborative efforts of oncologists and coagulation/vascular experts to identify, further develop, and implement advances in thrombosis and hemostasis research into practice for cancer patients. The purpose of this FOA is to 1) encourage studies in selected cancer types that expand mechanistic investigation into the intersection between cancer and thrombotic pathways; and 2) apply mechanistic insights towards the identification and development of biomarkers of thrombotic risk or cancer progression and new strategies for preventing or treating the deleterious interplay between cancer, cancer therapy, and hemostasis/thrombosis.
Due Dates: Letter of Intent is due 30 days prior to submission date
Oct. 19 (OSR) Ι Oct. 23 (Sponsor)
Amount & Project Period: $500,000/yr. (Direct Costs) - 5 years  
Additional $100,000 in direct costs per year for site selected to serve as Administrative Coordinating Center.  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-HL-18-021
U01 NCI

October 24 (LOI) All Ranks Federal Systems Biology

Emerging Questions in Cancer Systems Biology

This FOA invites cooperative agreement applications for Research Projects that utilize systems biology approaches to address emerging questions in cancer initiation, progression, and treatment.  Research Projects proposed in response to this FOA must demonstrate explicit integration of experimental biology and computational modeling to test and validate novel hypotheses in cancer research.
Due Dates: Oct. 24 (Letter of Intent)
Nov. 22 (OSR) Ι Nov. 24 (Sponsor)
Additional Due Date:  June 22 & Nov. 23, 2018
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-131



October 31 All Ranks - See Below Non-Federal Ovarian

Kaleidoscope of Hope (KOH) Ovarian Cancer Research  Foundation
2018 Request for Proposals
General Research Grants & Young Investigator Grants

Proposals in the following areas will be considered:
Early Detection of Ovarian Cancer including precursor cell studies
and
 Treatment of Ovarian Cancer. 
The following areas will not be considered: survivorship topics, patient education or care resources and awareness education. 
Due Dates: Due Dates: Oct. 27 (OSR) Ι Oct. 31 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: RFP
 

General Grants  

Research proposals may be individual projects or part of a larger project related to ovarian cancer. Proposals for clinical trials must be original investigational studies related to ovarian cancer in which the grantee is the primary investigator (PI) or co-PI.
Amount & Project Period: $50,000 -1 year
Eligibility: Established Investigators

Young Investigator (YI) Grants

Young investigator grants support career development in the area of ovarian cancer research.
Amount & Project Period: $50,000 -1 year
Eligibility: A post-doctoral fellow or asst. professor w/in 5 years (excluding clinical training) of completing terminal degree. OR
An assistant professor (or equiv.) w/in 3 years of initiating independent research.
Must have the support of a qualified mentor




November 01 (LOI) All Faculty Ranks Non-Federal Immunotherapies

Clinic Laboratory Integration Program (CLIP)

CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.
Due Dates: Nov. 01 (Letter of Intent)
Invited Applications:  Jan. 30 (OSR) Feb. 01, 2018 (Sponsor)
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Tenure Track Assistant Professor or higher (By award activation)
No citizenship restrictions
Contact: Office of Sponsored Research (x6804)
Link: CLIP Application Guidelines


November 01 All Ranks Non-Federal Career Development

American College of Surgeons
Faculty Research Fellowships

The purpose is to provide support to surgeons entering academic careers in surgery or a surgical specialty. The fellowship is to assist a surgeon in the establishment of their research program under mentorship with the goal of transitioning to becoming an independent investigator. Applicants should have demonstrated their potential to work as independent investigators.
Due Dates: Oct. 30 (OSR) Ι Nov. 01 (Sponsor)
Amount & Project Period: $80,000 - 2 years
Eligibility: Applicant must have:
(1) Completed chief residency year or accredited fellowship training w/in preceding 5 years, not including time off for maternity leave, military deployment, or medical leave; and (2) Received a full-time faculty appointment in a department of surgery or a surgical specialty.
Applicants who have previously won an award from another professional society or NIH are not eligible.
A minimum of 50% effort must be committed to research proposed in application, and may run concurrently with effort requirements of NIH or other accepted funding.
Contact: Office of Sponsored Research (x6804)
Link: ACS Faculty Research Fellowships



November 07 All Ranks Non-federal Upper Gastrointestinal Malignancies

DeGregorio Family Foundation
8th Annual DeGregorio Foundation Award for Cancers of the Esophagus and Stomach

The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies.  Sought is high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.  Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported.
Due Dates: Nov. 03 (OSR) Ι Nov. 07 (Sponsor)
Amount & Project Period: $250,000 (TOTAL) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


November 10 All Faculty Ranks Non-Federal Melanoma

Harry J. Lloyd Charitable Trust
Melanoma Research Grants

Awards are made in three categories:  Career Development for promising young melanoma investigators, Basic Science for the purpose of gaining new biological insights in to melanoma development or progression, and Translational Research to fund clinically important melanoma research.  Special consideration will be given in three areas: 1) emerging novel concepts that constitute significant innovation, 2) new investigators in the field of melanoma, and 3) prevention and early detection.
Due Dates: Nov. 08 (OSR) Ι Nov. 10 (Sponsor)
Amount & Project Period: Career Development - $125,000/yr. - 3 years
Basic Science - $125,000/yr. - 3 years
Translational Science - $125,000/yr. - 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines


Updated
November 15 (LOI) All Faculty Ranks Non-Federal Immunotherapies

Technology Impact Grants

The grant aims to support development of highly innovative technologies that can ultimately be adopted by the research community at large and will enable researchers to develop the next generation cancer immunotherapies that can be effective and personalized for each patient. Technologies may facilitate understanding of the antigenic profile, cellular interplay, and mechanistic pathways within the tumor microenvironment that are essential for an effective anti-tumor response.
Due Dates: Nov. 15 (Letter of Intent)
Invited Applications:  Mar. 13 (OSR) Ι Mar. 15, 2018 (Sponsor)
Amount & Project Period: Up to $200,000 (Total Cost) - 2 years
Eligibility: Tenure Track Assistant Professor or higher
Contact: Office of Sponsored Research (x6804)
Link: Overview | Impact Grants   



November 17 See Below Non-Federal Melanoma

Melanoma Research Alliance 2017-2018 Cycle

MRA is soliciting proposals that address the gap in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and melanoma patients).
Due Dates: Nov. 15 (OSR) Ι Nov. 17 at 5p.m. (Sponsor)
Contact: Office of Sponsored Research (x6804)
To confirm eligibility contact Tasheema Prince at tprince@curemelanoma.org
Link: Overview  Ι  RFP
 

Young Investigator Award

Young Investigator Awards aim to attract early career scientists with novel ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders and to help achieve innovative and creative, preclinical, translational, and/or early clinical research projects.
Amount & Project Period: $75,000/yr (Total cost) - 3 years  
Eligibility: Must be within four years of first independent, full time academic faculty appointment at the time of application at the level of Assistant Professor (or equivalent position).
 

Young Investigator Award for Women in Scientific Research

 MRA is proud to offer a Young Investigator Award with the goal of attracting and supporting early career female researchers who are conducting cutting-edge melanoma research. This award will support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging or treatment of melanoma.
Amount & Project Period: $225,000 (Total cost) - 3 years  
Eligibility: Must be a woman.
Must be within four years of first independent, full time academic faculty appointment at the time of application at the level of Assistant Professor (or equivalent position).


NEW
November 21 (Pre-Application) See Below Federal Breast

Breast Cancer Research Program (BCRP)

Due Dates: Nov. 21 (Pre-Application)
Full applications due: Dec. 04 (OSR) Ι Dec. 06 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: BCRP Program Announcements Ι Pre-Application Site
 

Era of Hope Scholar Award II
W81XWH-17-BCRP-EOHS2

This award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer.
Amount & Project Period: $2.5M (Direct Costs) - 4 years  
Eligibility: Must be an independent investigator within 6 years of last training position as of the application submission deadline.
PA Link: W81XWH-17-BCRP-EOHS2
 

Breakthrough Fellowship II
W81XWH-17-BCRP-Breakthrough_Fellowship2

This award supports recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research during their postdoctoral fellowship and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research.
Amount & Project Period: $300,000 (Direct Costs) - 3 years
Eligibility: Must have been in laboratory or clinical research setting where proposed research is to be performed for no more than 2 years as a postdoc, and have a total of less than 4 years' experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training)
PA Link: W81XWH-17-BCRP-Breakthrough_Fellowship2
 

Breakthrough Award Levels 1 & 2
W81XWH-17-BCRP-BREAKTHROUGH2-FL12

Research proposed may be small- to large-scale projects, at different stages of idea and research development. Two different funding levels, based on the scope of the research, are available. Funding Level 1 is for innovative, high-risk/high-reward research in the earliest stages of idea development. Research with potential to yield new avenues of investigation. Proof of concept. No preliminary data required. Funding Level 2 is for research already supported by preliminary data having potential to make significant advancements toward clinical translation.
Amount & Project Period: Level 1:  $375,000 - 3 years
Partnering Option:  $600,000 (Combined direct Costs)
Level 2:  $750,000 - 3 years
Partnering Option:  $1M (Combined direct Costs)
The Partnering PI Option is structured to accommodate two PIs referred to as the Initiating PI and the Partnering PI, each of whom will receive a separate award. (See FOA for details)
Eligibility: Investigators at all academic levels
PA Link: W81XWH-17-BCRP-BREAKTHROUGH2-FL12
R01 NCI


November 21 All Ranks Federal Nanotechnology

Innovative Research in Cancer Nanotechnology (IRCN)

IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposals should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. Scope includes research concerning the delivery of nanoparticles and/or nanodevices to desired and intended cancer targets in vivo and/or characterization of in vitro detection and diagnostic devices.
Due Dates: Nov. 17 (OSR) Ι Nov. 21 (Sponsor)
Amount & Project Period: Limited to $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-240




NEW
November 30 Post Docs Non-Federal Lung

Lung Cancer Foundation of America-Bristol-Myers Squibb/ International Association for the Study of Lung Cancer
Young Investigator Research Fellowships in Translational Immuno-Oncology

The objective of the LCFA-BMS/IASLC Young Investigator Research Fellowships is to support research in translational immuno-oncology by early career investigators that aim to improve the care of individuals with lung cancers and to reduce the burden of these diseases.
Due Dates: Nov. 28 (OSR) Ι Nov. 30 (Sponsor)
Amount & Project Period: $100,000/yr (Total Costs) - 2 years  
Eligibility: Have less than 5 years of postdoctoral experience
Be actively engaged in research evaluating the use of the immune system,
Contact: Office of Sponsored Research (x6804)
RFA Link: 2017 RFA


NEW
December 01 See Below Non-Federal Career Development

Damon Runyon Cancer Research Foundation
Physician-Scientist Training Award

The purpose of this FOA is to recruit outstanding U.S. specialty board- eligible physicians into cancer research careers. This award is structured to provide recipients with significant salary support and necessary research expenses.
Due Dates: Nov. 29 (OSR) Ι Dec. 01 (Sponsor)
Amount & Project Period: $460,000 (Total Costs) - 4 years  
Eligibility: Must not have more than 3 years of post doctoral experience. MD/PhDs not eligible to apply.
Must not have an Assistant Professorship or equivalent appointment.
Must not have received a K award.
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Application Guidelines


NEW
December 01 See Below Non-Federal Ovarian

Rivkin Center for Ovarian Cancer

Due Dates: Nov. 29 (OSR) Ι Dec. 01 (Sponsor) (5:00p.m., EST)
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι proposalCENTRAL
 

Pilot Study Program

This Pilot Study Program will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered.
Amount & Project Period: $75,000 (Total Costs) - 1 year  
Eligibility: All Faculty
Link: Guidelines Ι RFA
 

Scientific Scholar Award

The Scientific Scholar Award is intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator in ovarian cancer research.
Amount & Project Period: $120,000 (Total Costs) - 2 years  
Eligibility: Must have an MD, PhD or equivalent.
No more than 3-4 years as a post doc, research assistant, or assistant professor.
Clinician must have completed residency.
Link: Guidelines Ι RFA




December 01 All Ranks Non-Federal Clinical Oncology

Hope Foundation
SWOG Early Exploration and Development (SEED) Fund

 This award is a funding program from the Hope Foundation that encourages preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). This award may assist investigators with projects that support the following: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: Nov. 29 (OSR) Ι Dec. 01 (5:00, pm ET) (Sponsor)
Amount & Project Period: $50,000 (Direct Costs) - 1-2 years  
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program
Contact: Office of Sponsored Research (x6804)
Link: SEED Fund Award  Ι  2017  RFA


NEW
December 15 Junior Faculty Non-Federal Pancreatic Cancer

Pancreatic Cancer Action Network Catalyst Grant

The Pancreatic Cancer Action Network Catalyst Grant represents an effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.
Due Dates: Dec. 13 (OSR) Ι Dec. 15 (12:00 p.m., EST) (Sponsor)
Amount & Project Period: $500,000 (Total Costs) - 3 years  
Eligibility: Must hold a faculty position at start of grant term.
Must have independent laboratory space.
Not have currently or previously served as a PI on major research awards or grants.
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Guidelines Ι FAQ


NEW
January 12 See Below Non-Federal Gastroenterology

American Gastroenterological Association

Due Dates: Jan. 10 (OSR) Ι Jan. 12 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: AGA Program announcements
 

Caroline Craig Augustyn & Damian Augustyn Award

This opportunity is to support early career investigators conducting research relevant to the pathogenesis, prevention, diagnosis, or treatment of digestive cancer. The award is intended to supplement existing career development funding.
Amount & Project Period: $40,000 (Total Costs) - 1 year  
Eligibility: Must be an AGA member.
Must hold a federal or non-federal career development award related to digestive cancer. 
Must hold a full-time faculty position.
Must not have an R01 award or equivalent.
Link: Guidelines
 

Elsevier Pilot Research Award

The objective of this pilot research award is to provide funds to early career investigators to help establish their research careers, or to support projects that represent new research directions for established investigators. 
Amount & Project Period: $25,000 (Total Costs) - 1 year 
Eligibility: Must be an AGA member.  
Must hold a full-time faculty position.   
Link:  Guidelines
 

Boston Scientific Technology and Innovation Pilot Award

The objective of this pilot research award is to provide funds for early career investigators or established investigators pursuing new research directions. Projects must focus on medical technologies relevant to the diagnosis or treatment of digestive or liver diseases.
Amount & Project Period: $30,000 (Total Costs) - 1 year  
Eligibility: Must be an AGA member.
Must have a full-time faculty position.   
Link: Guidelines
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org